354 related articles for article (PubMed ID: 19427832)
1. Non-hypoxic activation of the negative regulatory feedback loop of prolyl-hydroxylase oxygen sensors.
Tug S; Delos Reyes B; Fandrey J; Berchner-Pfannschmidt U
Biochem Biophys Res Commun; 2009 Jul; 384(4):519-23. PubMed ID: 19427832
[TBL] [Abstract][Full Text] [Related]
2. Prolyl hydroxylases 2 and 3 act in gliomas as protective negative feedback regulators of hypoxia-inducible factors.
Henze AT; Riedel J; Diem T; Wenner J; Flamme I; Pouyseggur J; Plate KH; Acker T
Cancer Res; 2010 Jan; 70(1):357-66. PubMed ID: 20028863
[TBL] [Abstract][Full Text] [Related]
3. Overexpression and nuclear translocation of hypoxia-inducible factor prolyl hydroxylase PHD2 in head and neck squamous cell carcinoma is associated with tumor aggressiveness.
Jokilehto T; Rantanen K; Luukkaa M; Heikkinen P; Grenman R; Minn H; Kronqvist P; Jaakkola PM
Clin Cancer Res; 2006 Feb; 12(4):1080-7. PubMed ID: 16489060
[TBL] [Abstract][Full Text] [Related]
4. Hypoxia-inducible factor prolyl-hydroxylase: purification and assays of PHD2.
Hewitson KS; Schofield CJ; Ratcliffe PJ
Methods Enzymol; 2007; 435():25-42. PubMed ID: 17998047
[TBL] [Abstract][Full Text] [Related]
5. Hypoxia inducible factor-1 activation by prolyl 4-hydroxylase-2 gene silencing attenuates myocardial ischemia reperfusion injury.
Natarajan R; Salloum FN; Fisher BJ; Kukreja RC; Fowler AA
Circ Res; 2006 Jan; 98(1):133-40. PubMed ID: 16306444
[TBL] [Abstract][Full Text] [Related]
6. Age-dependent increase of prolyl-4-hydroxylase domain (PHD) 3 expression in human and mouse heart.
Rohrbach S; Simm A; Pregla R; Franke C; Katschinski DM
Biogerontology; 2005; 6(3):165-71. PubMed ID: 16041620
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of the catalytic activity of hypoxia-inducible factor-1alpha-prolyl-hydroxylase 2 by a MYND-type zinc finger.
Choi KO; Lee T; Lee N; Kim JH; Yang EG; Yoon JM; Kim JH; Lee TG; Park H
Mol Pharmacol; 2005 Dec; 68(6):1803-9. PubMed ID: 16155211
[TBL] [Abstract][Full Text] [Related]
8. HIF-prolyl hydroxylases and cardiovascular diseases.
Sen Banerjee S; Thirunavukkarasu M; Tipu Rishi M; Sanchez JA; Maulik N; Maulik G
Toxicol Mech Methods; 2012 Jun; 22(5):347-58. PubMed ID: 22424133
[TBL] [Abstract][Full Text] [Related]
9. Oxygen sensing by the prolyl-4-hydroxylase PHD2 within the nuclear compartment and the influence of compartmentalisation on HIF-1 signalling.
Pientka FK; Hu J; Schindler SG; Brix B; Thiel A; Jöhren O; Fandrey J; Berchner-Pfannschmidt U; Depping R
J Cell Sci; 2012 Nov; 125(Pt 21):5168-76. PubMed ID: 22946054
[TBL] [Abstract][Full Text] [Related]
10. Nitric oxide modulates oxygen sensing by hypoxia-inducible factor 1-dependent induction of prolyl hydroxylase 2.
Berchner-Pfannschmidt U; Yamac H; Trinidad B; Fandrey J
J Biol Chem; 2007 Jan; 282(3):1788-96. PubMed ID: 17060326
[TBL] [Abstract][Full Text] [Related]
11. The peptidyl prolyl cis/trans isomerase FKBP38 determines hypoxia-inducible transcription factor prolyl-4-hydroxylase PHD2 protein stability.
Barth S; Nesper J; Hasgall PA; Wirthner R; Nytko KJ; Edlich F; Katschinski DM; Stiehl DP; Wenger RH; Camenisch G
Mol Cell Biol; 2007 May; 27(10):3758-68. PubMed ID: 17353276
[TBL] [Abstract][Full Text] [Related]
12. Oxygen-sensing under the influence of nitric oxide.
Berchner-Pfannschmidt U; Tug S; Kirsch M; Fandrey J
Cell Signal; 2010 Mar; 22(3):349-56. PubMed ID: 19861159
[TBL] [Abstract][Full Text] [Related]
13. Role of N-acetyl-N-nitroso-tryptophan as nitric oxide donor in the modulation of HIF-1-dependent signaling.
Berchner-Pfannschmidt U; Tug S; Hu J; Reyes BD; Fandrey J; Kirsch M
Biol Chem; 2010 May; 391(5):533-40. PubMed ID: 20302516
[TBL] [Abstract][Full Text] [Related]
14. Essential role for prolyl hydroxylase domain protein 2 in oxygen homeostasis of the adult vascular system.
Takeda K; Cowan A; Fong GH
Circulation; 2007 Aug; 116(7):774-81. PubMed ID: 17646578
[TBL] [Abstract][Full Text] [Related]
15. Prolyl-hydroxylase inhibition and HIF activation in osteoblasts promotes an adipocytic phenotype.
Irwin R; LaPres JJ; Kinser S; McCabe LR
J Cell Biochem; 2007 Feb; 100(3):762-72. PubMed ID: 17031858
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of prolyl hydroxylase domain proteins promotes therapeutic revascularization.
Loinard C; Ginouvès A; Vilar J; Cochain C; Zouggari Y; Recalde A; Duriez M; Lévy BI; Pouysségur J; Berra E; Silvestre JS
Circulation; 2009 Jul; 120(1):50-9. PubMed ID: 19546390
[TBL] [Abstract][Full Text] [Related]
17. Short-term effects of pharmacologic HIF stabilization on vasoactive and cytotrophic factors in developing mouse brain.
Schneider C; Krischke G; Keller S; Walkinshaw G; Arend M; Rascher W; Gassmann M; Trollmann R
Brain Res; 2009 Jul; 1280():43-51. PubMed ID: 19450570
[TBL] [Abstract][Full Text] [Related]
18. Analysis of HIF-prolyl hydroxylases binding to substrates.
Landázuri MO; Vara-Vega A; Vitón M; Cuevas Y; del Peso L
Biochem Biophys Res Commun; 2006 Dec; 351(2):313-20. PubMed ID: 17069766
[TBL] [Abstract][Full Text] [Related]
19. An activator of PHD2, KRH102140, decreases angiogenesis via inhibition of HIF-1α.
Nepal M; Gong YD; Park YR; Soh Y
Cell Biochem Funct; 2011 Mar; 29(2):126-34. PubMed ID: 21287578
[TBL] [Abstract][Full Text] [Related]
20. Prolyl hydroxylases as regulators of cell metabolism.
Boulahbel H; Durán RV; Gottlieb E
Biochem Soc Trans; 2009 Feb; 37(Pt 1):291-4. PubMed ID: 19143649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
